IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BUGLIONE DI MONALE E BASTIA, MICHELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.338
AS - Asia 5.594
EU - Europa 4.934
SA - Sud America 1.022
AF - Africa 146
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 24.068
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.147
SG - Singapore 1.951
CN - Cina 1.880
UA - Ucraina 1.003
BR - Brasile 864
DE - Germania 809
IT - Italia 750
HK - Hong Kong 663
PL - Polonia 613
FI - Finlandia 374
FR - Francia 357
VN - Vietnam 335
GB - Regno Unito 291
RU - Federazione Russa 253
TR - Turchia 234
IE - Irlanda 191
IN - India 164
CA - Canada 92
BD - Bangladesh 69
MX - Messico 59
AR - Argentina 56
ZA - Sudafrica 55
IQ - Iraq 48
SE - Svezia 46
ID - Indonesia 45
CZ - Repubblica Ceca 43
NL - Olanda 39
JP - Giappone 34
EC - Ecuador 32
ES - Italia 32
PK - Pakistan 24
UZ - Uzbekistan 24
CO - Colombia 22
AT - Austria 21
BE - Belgio 20
VE - Venezuela 20
NG - Nigeria 19
MA - Marocco 18
SA - Arabia Saudita 18
AU - Australia 17
LT - Lituania 15
EU - Europa 14
TN - Tunisia 13
GR - Grecia 12
EG - Egitto 10
IR - Iran 10
PA - Panama 10
CL - Cile 9
JO - Giordania 9
PY - Paraguay 9
BY - Bielorussia 8
MY - Malesia 8
NP - Nepal 8
OM - Oman 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
DZ - Algeria 7
IL - Israele 7
JM - Giamaica 7
KE - Kenya 7
SN - Senegal 7
CH - Svizzera 6
HU - Ungheria 6
KG - Kirghizistan 6
AZ - Azerbaigian 5
PH - Filippine 5
PT - Portogallo 5
TW - Taiwan 5
BG - Bulgaria 4
BO - Bolivia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
HN - Honduras 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
KH - Cambogia 3
KR - Corea 3
KW - Kuwait 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MU - Mauritius 3
NO - Norvegia 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
UY - Uruguay 3
AM - Armenia 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
IS - Islanda 2
PE - Perù 2
SL - Sierra Leone 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
Totale 24.050
Salva come PNG Salva come JPEG
Città #
Fairfield 1.294
Ashburn 1.272
Woodbridge 1.075
Singapore 1.066
Jacksonville 722
Houston 690
Hong Kong 658
Warsaw 602
Seattle 571
Cambridge 535
Chandler 529
Ann Arbor 494
Wilmington 466
Beijing 418
San Jose 398
The Dalles 385
New York 351
Princeton 335
Los Angeles 227
Helsinki 219
Nanjing 208
Dublin 190
Istanbul 175
Lauterbourg 175
Dearborn 172
Munich 143
Dallas 134
Brescia 112
Ho Chi Minh City 94
Milan 92
Shanghai 92
São Paulo 91
Buffalo 90
Nanchang 90
Des Moines 89
Moscow 83
San Francisco 83
Council Bluffs 76
San Diego 71
Changsha 60
Orem 58
Dong Ket 52
Hanoi 51
Jinan 49
Shenyang 49
Hebei 48
Tianjin 48
Chicago 47
Redondo Beach 46
London 45
Turku 45
Washington 44
Santa Clara 43
Boardman 42
Jiaxing 36
Montreal 35
Chennai 34
Kunming 34
Denver 33
Nuremberg 33
Johannesburg 31
Tokyo 31
Brooklyn 29
Hangzhou 29
Jakarta 28
Poplar 28
Toronto 28
Rio de Janeiro 27
Brno 26
Frankfurt am Main 25
Lancaster 25
Zhengzhou 25
Manchester 24
Mexico City 22
Tashkent 22
Ningbo 21
Phoenix 21
Rome 21
Brussels 20
Brasília 19
Abuja 18
Kocaeli 18
Stockholm 18
Amsterdam 17
Da Nang 17
Guangzhou 17
Atlanta 16
Boston 16
Ceto 16
Dhaka 16
Haikou 16
Mumbai 16
Taizhou 16
Ankara 15
Curitiba 15
Lanzhou 15
Nürnberg 15
Quito 15
Verona 15
Baronissi 14
Totale 16.322
Salva come PNG Salva come JPEG
Nome #
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 273
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 265
Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma 264
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 248
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 246
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 225
Pros-IT CNR: an Italian prostate cancer monitoring project 220
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 218
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 210
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 209
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 205
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 202
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 199
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 195
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 192
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 190
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 189
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 188
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 187
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 182
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 181
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 181
Radiotherapy in patients with HIV: current issues and review of the literature 180
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 179
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 175
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 173
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 173
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 172
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 171
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 171
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 170
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 169
Role of external beam radiotherapy in the treatment of relapsing meningioma 169
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 168
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 168
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 167
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 165
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 165
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 164
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 164
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 161
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 161
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 161
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 161
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 160
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 160
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 160
From Molecular to Clinical Radiation Biology of Glioblastoma 159
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 159
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 156
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 156
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 156
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 155
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 155
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 154
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 153
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 153
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 152
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 152
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 150
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 150
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 150
Letter to “Medial lingual lymph node metastasis in carcinoma of the tongue” 149
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 148
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 146
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 145
Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection? 144
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 143
Cetuximab and Radiation Therapy in Head and Neck Cancer 142
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 142
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 139
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 138
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 138
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 138
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 138
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 137
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 136
Information Retrieval in Medicine: an Extensive Experimental Study 136
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 136
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 135
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 135
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 133
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 132
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 132
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 130
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 129
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 128
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 128
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 128
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 128
Post-ABVD/pre-radiotherapy 18F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: A retrospective analysis on 165 patients 128
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 126
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 125
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 125
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 125
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) 124
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 123
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 123
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 123
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 122
Totale 16.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021848 0 0 0 0 0 0 0 0 0 393 260 195
2021/20221.346 110 196 37 58 16 75 53 112 74 160 86 369
2022/20231.350 187 88 46 103 124 336 6 137 211 16 53 43
2023/20241.800 87 32 190 93 94 412 63 80 348 51 79 271
2024/20253.357 31 41 29 487 332 298 283 138 316 286 720 396
2025/20266.464 675 913 489 931 760 485 1.045 246 463 457 0 0
Totale 24.474